Assignee
IMPAX LABORATORIES INC
US·12 granted patents·5 pending applications·388 citations·filing 2000–2019
Top patents by PatentIndex Score
17 records- 0197US10292935B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted May 21, 2019·30 cites·20 claims
- 0297US8377474B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2008·Granted Feb 19, 2013·48 cites·82 claims
- 0395US10098845B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2014·Granted Oct 16, 2018·28 cites·22 claims
- 0492US6333332B1Stabilized pharmaceutical compositions containing bupropion hydrochlorideIMPAX LABORATORIES INC·Filed 2000·Granted Dec 25, 2001·170 cites·55 claims
- 0591US8007827B2Pharmaceutical dosage forms having immediate release and/or controlled release propertiesIMPAX LABORATORIES INC·Filed 2005·Granted Aug 30, 2011·17 cites·45 claims
- 0690US7094427B2Combination immediate release controlled release levodopa/carbidopa dosage formsIMPAX LABORATORIES INC·Filed 2002·Granted Aug 22, 2006·60 cites·31 claims
- 0788US9089608B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·6 cites·21 claims
- 0886US9089607B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·5 cites·56 claims
- 0982US9463246B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Oct 11, 2016·3 cites·54 claims
- 1080US6531158B1Drug delivery system for enhanced bioavailability of hydrophobic active ingredientsIMPAX LABORATORIES INC·Filed 2000·Granted Mar 11, 2003·21 cites·19 claims
- 1165US9901640B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted Feb 27, 2018·0 cites·25 claims
- 1265US2016296463A1Rapidly disintegrating formulations and methods thereofIMPAX LABORATORIES INC·Filed 2014·Application pending·0 cites
- 1364US2019365641A1Rapidly disintegrating formulations and methods of useIMPAX LABORATORIES INC·Filed 2019·Application pending·0 cites
- 1461US9533046B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2015·Granted Jan 3, 2017·0 cites·31 claims
- 1548US2005147670A1Oral disintegrating dosage formsIMPAX LABORATORIES INC·Filed 2004·Application pending·0 cites
- 1647US2005226927A1Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonistIMPAX LABORATORIES INC·Filed 2005·Application pending·0 cites
- 1739US2006013875A1Combination immediate release controlled release levodopa/carbidopa dosage formsIMPAX LABORATORIES INC·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →